271
Views
7
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma

, , , , , , , , , , , , , , , , , & show all
Pages 1043-1049 | Received 17 Feb 2014, Accepted 30 Aug 2014, Published online: 20 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xavier Thomas. (2023) T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development. Expert Opinion on Investigational Drugs 32:1, pages 37-52.
Read now
Mingyang Wang, Xiaosheng Fang & Xin Wang. (2020) Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma. Leukemia & Lymphoma 61:4, pages 763-775.
Read now
Parastoo B. Dahi, Craig H. Moskowitz, Sergio A. Giralt & Hillard M. Lazarus. (2019) Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma. Expert Review of Hematology 12:6, pages 407-418.
Read now
Parastoo B. Dahi, Craig H. Moskowitz, Sergio A. Giralt & Hillard M. Lazarus. (2019) Novel agents positively impact chemotherapy and transplantation in Hodgkin lymphoma. Expert Review of Hematology 12:4, pages 255-264.
Read now

Articles from other publishers (3)

Yi Miao, L. Jeffrey Medeiros, Yong Li, Jianyong Li & Ken H. Young. (2019) Genetic alterations and their clinical implications in DLBCL. Nature Reviews Clinical Oncology 16:10, pages 634-652.
Crossref
Parastoo B. Dahi, Hillard M. Lazarus, Craig S. Sauter & Sergio A. Giralt. (2018) Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma. Bone Marrow Transplantation 54:7, pages 943-960.
Crossref
Björn Tampe & Michael Zeisberg. (2018) Chromatin dynamics at the core of kidney fibrosis. Matrix Biology 68-69, pages 194-229.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.